| Target Price | $96.90 |
| Price | $91.78 |
| Potential | 5.58% |
| Number of Estimates | 29 |
| 29 Analysts have issued a price target Coca-Cola 2027 . The average Coca-Cola target price is $96.90. This is 5.58% higher than the current stock price. The highest price target is $109.20 18.98% , the lowest is $72.09 21.45% . | |
| A rating was issued by 35 analysts: 27 Analysts recommend Coca-Cola to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Coca-Cola stock has an average upside potential 2027 of 5.58% . Most analysts recommend the Coca-Cola stock at Purchase. |
29 Analysts have issued a sales forecast Coca-Cola 2026 . The average Coca-Cola sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
22 Analysts have issued an Coca-Cola EBITDA forecast 2026. The average Coca-Cola EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
29 Coca-Cola Analysts have issued a net profit forecast 2026. The average Coca-Cola net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 05 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Sep 28 2026 |
| Argus Research |
Buy
➜
Buy
|
Unchanged | Jul 30 2026 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 30 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 29 2026 |
| Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Jul 29 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Jul 29 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 05 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Sep 28 2026 |
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Jul 30 2026 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 30 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 29 2026 |
|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Jul 29 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Jul 29 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


